{"gao_id": "GAO-23-106210", "published": "2022-10-17T12:00:00Z", "released": "2022-10-17T08:00:00Z", "summary": "The U.S. Strategic National Stockpile is a multibillion dollar inventory of medical countermeasures\u2014medication, supplies, and more\u2014that can be used in emergencies. COVID-19 underscored its importance. The Department of Health and Human Services' inventory planning reports didn't meet most legal requirements enacted in 2019 or communicate risks associated with not meeting recommended inventory levels. This is partly because HHS hasn't updated its processes for completing the...", "title": "Public Health Preparedness: HHS Should Address Strategic National Stockpile Requirements and Inventory Risks", "topics": ["National Defense", "Anthrax", "Health care", "Inventory", "Medical countermeasures", "National preparedness", "pandemics", "Public health", "Public health emergencies", "Strategic national stockpile", "Supply chain management"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-106210", "versions": [{"title": "Highlights Page (2 pages)", "url": "https://www.gao.gov/assets/gao-23-106210-highlights.pdf"}, {"title": "Full Report (71 pages)", "url": "https://www.gao.gov/assets/gao-23-106210.pdf"}, {"title": "Accessible PDF (83 pages)", "url": "https://www.gao.gov/assets/730/723430.pdf"}]}